(INVZ) Innoviz Technologies - Ratings and Ratios
Solid-State LiDAR, Long-Range LiDAR, Short-Range LiDAR, Perception Software
INVZ EPS (Earnings per Share)
INVZ Revenue
Description: INVZ Innoviz Technologies October 27, 2025
Innoviz Technologies Ltd. (NASDAQ: INVZ) designs and manufactures automotive-grade solid-state LiDAR sensors and accompanying perception software aimed at enabling mass-scale autonomous driving. Its product lineup includes the InnovizOne sensor for automakers and robotaxi fleets, the InnovizTwo Long-Range and Short-to-Mid-Range variants for higher-performance use cases, and a software suite that converts raw point-cloud data into actionable perception outputs. The company sells globally-covering Europe, APAC, the Middle East, Africa, Israel, and North America-through a mix of direct sales and distribution partners, and is headquartered in Rosh HaAyin, Israel.
Key industry metrics that shape Innoviz’s growth prospects include a projected 22 % CAGR for the automotive LiDAR market through 2030 (according to IDTechEx) and an estimated total addressable market of roughly $12 billion for solid-state LiDAR in passenger vehicles. In its most recent quarterly filing (Q2 2024), Innoviz reported a 48 % year-over-year increase in revenue, driven largely by new supply agreements with a major European OEM and a pilot deployment with a leading robotaxi operator in the United States. The firm’s gross margin improved to 38 % after scaling production volumes, reflecting the cost advantages of its silicon-photonic architecture.
For a deeper, data-driven assessment of Innoviz’s valuation and risk profile, you may find ValueRay’s analytical tools useful for independent research.
INVZ Stock Overview
| Market Cap in USD | 406m |
| Sub-Industry | Automotive Parts & Equipment |
| IPO / Inception | 2021-04-05 |
INVZ Stock Ratings
| Growth Rating | -20.2% |
| Fundamental | 37.5% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 125% |
| Analyst Rating | 4.25 of 5 |
INVZ Dividends
Currently no dividends paidINVZ Growth Ratios
| Growth Correlation 3m | 52.1% |
| Growth Correlation 12m | 62.9% |
| Growth Correlation 5y | -90.2% |
| CAGR 5y | -32.87% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.36 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.50 |
| Sharpe Ratio 12m | -0.04 |
| Alpha | 139.53 |
| Beta | 1.275 |
| Volatility | 89.85% |
| Current Volume | 4597k |
| Average Volume 20d | 5253.4k |
| Stop Loss | 1.5 (-10.2%) |
| Signal | -0.82 |
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-74.6m TTM) > 0 and > 6% of Revenue (6% = 2.26m TTM) |
| FCFTA -0.43 (>2.0%) and ΔFCFTA 9.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 192.6% (prev 269.1%; Δ -76.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.39 (>3.0%) and CFO -59.4m > Net Income -74.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (200.8m) change vs 12m ago 20.56% (target <= -2.0% for YES) |
| Gross Margin 23.66% (prev -18.84%; Δ 42.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.71% (prev 19.25%; Δ 4.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -52.90 (EBITDA TTM -70.0m / Interest Expense TTM 1.45m) >= 6 (WARN >= 3) |
Altman Z'' -30.28
| (A) 0.48 = (Total Current Assets 100.9m - Total Current Liabilities 28.3m) / Total Assets 151.1m |
| (B) -5.04 = Retained Earnings (Balance) -761.2m / Total Assets 151.1m |
| warn (B) unusual magnitude: -5.04 — check mapping/units |
| (C) -0.48 = EBIT TTM -76.4m / Avg Total Assets 159.0m |
| (D) -13.13 = Book Value of Equity -761.2m / Total Liabilities 58.0m |
| Total Rating: -30.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.46
| 1. Piotroski 1.50pt = -3.50 |
| 2. FCF Yield -17.90% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.38 = 2.43 |
| 5. Debt/Ebitda -0.31 = -2.50 |
| 6. ROIC - WACC (= -92.50)% = -12.50 |
| 7. RoE -80.09% = -2.50 |
| 8. Rev. Trend 83.01% = 6.23 |
| 9. EPS Trend 96.07% = 4.80 |
What is the price of INVZ shares?
Over the past week, the price has changed by -10.22%, over one month by -28.63%, over three months by +2.45% and over the past year by +156.37%.
Is Innoviz Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INVZ is around 1.26 USD . This means that INVZ is currently overvalued and has a potential downside of -24.55%.
Is INVZ a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the INVZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.9 | 73.7% |
| Analysts Target Price | 2.9 | 73.7% |
| ValueRay Target Price | 1.4 | -15% |
INVZ Fundamental Data Overview October 27, 2025
P/S = 10.7623
P/B = 4.5709
Beta = 1.275
Revenue TTM = 37.7m USD
EBIT TTM = -76.4m USD
EBITDA TTM = -70.0m USD
Long Term Debt = 35.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.3m USD (from shortTermDebt, last quarter)
Debt = 35.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.7m USD (from netDebt column, last quarter)
Enterprise Value = 361.4m USD (405.6m + Debt 35.3m - CCE 79.4m)
Interest Coverage Ratio = -52.90 (Ebit TTM -76.4m / Interest Expense TTM 1.45m)
FCF Yield = -17.90% (FCF TTM -64.7m / Enterprise Value 361.4m)
FCF Margin = -171.7% (FCF TTM -64.7m / Revenue TTM 37.7m)
Net Margin = -197.9% (Net Income TTM -74.6m / Revenue TTM 37.7m)
Gross Margin = 23.66% ((Revenue TTM 37.7m - Cost of Revenue TTM 28.8m) / Revenue TTM)
Gross Margin QoQ = 16.00% (prev 40.15%)
Tobins Q-Ratio = 2.39 (Enterprise Value 361.4m / Total Assets 151.1m)
Interest Expense / Debt = 4.10% (Interest Expense 1.45m / Debt 35.3m)
Taxrate = -0.28% (negative due to tax credits) (51.0k / -18.4m)
NOPAT = -76.6m (EBIT -76.4m * (1 - -0.28%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 3.56 (Total Current Assets 100.9m / Total Current Liabilities 28.3m)
Debt / Equity = 0.38 (Debt 35.3m / totalStockholderEquity, last quarter 93.1m)
Debt / EBITDA = -0.31 (negative EBITDA) (Net Debt 21.7m / EBITDA -70.0m)
Debt / FCF = -0.34 (negative FCF - burning cash) (Net Debt 21.7m / FCF TTM -64.7m)
Total Stockholder Equity = 93.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -49.35% (Net Income -74.6m / Total Assets 151.1m)
RoE = -80.09% (Net Income TTM -74.6m / Total Stockholder Equity 93.1m)
RoCE = -59.54% (EBIT -76.4m / Capital Employed (Equity 93.1m + L.T.Debt 35.3m))
RoIC = -82.32% (negative operating profit) (NOPAT -76.6m / Invested Capital 93.1m)
WACC = 10.18% (E(405.6m)/V(440.8m) * Re(10.71%) + D(35.3m)/V(440.8m) * Rd(4.10%) * (1-Tc(-0.00)))
Discount Rate = 10.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 10.27%
Fair Price DCF = unknown (Cash Flow -64.7m)
EPS Correlation: 96.07 | EPS CAGR: 134.6% | SUE: 3.29 | # QB: 1
Revenue Correlation: 83.01 | Revenue CAGR: 140.0% | SUE: -1.50 | # QB: 0
Additional Sources for INVZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle